Insider Transactions in Q1 2022 at Hanover Insurance Group, Inc. (THG)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 29
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
2,725
-3.51%
|
$408,750
$150.47 P/Share
|
Mar 29
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,725
+3.39%
|
$109,000
$40.01 P/Share
|
Mar 28
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
4,533
-5.71%
|
$679,950
$150.09 P/Share
|
Mar 28
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,533
+5.4%
|
$181,320
$40.01 P/Share
|
Mar 25
2022
|
Bryan J Salvatore Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.12%
|
-
|
Mar 25
2022
|
Dennis Francis Kerrigan Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.49%
|
-
|
Mar 25
2022
|
Richard W Lavey Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.08%
|
-
|
Mar 25
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.24%
|
-
|
Mar 25
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
49
+0.07%
|
-
|
Mar 25
2022
|
Willard T Lee Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
Mar 25
2022
|
Denise Lowsley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.42%
|
-
|
Mar 25
2022
|
Mark Joseph Welzenbach Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.07%
|
-
|
Mar 25
2022
|
John C Roche President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
107
+0.14%
|
-
|
Mar 18
2022
|
Jeffrey M Farber Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
78,161
-38.0%
|
$11,333,345
$145.25 P/Share
|
Mar 18
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
105,022
+33.86%
|
$8,191,716
$78.19 P/Share
|
Mar 17
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
7,258
-4.48%
|
$1,052,410
$145.93 P/Share
|
Mar 17
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,258
+8.13%
|
$290,320
$40.01 P/Share
|
Mar 08
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
SELL
Open market or private sale
|
Direct |
649
-13.45%
|
$90,211
$139.74 P/Share
|
Mar 07
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-4.91%
|
$34,611
$139.52 P/Share
|
Mar 07
2022
|
Mark Joseph Welzenbach Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,077
-4.57%
|
$149,703
$139.52 P/Share
|
Mar 07
2022
|
Bryan J Salvatore Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,213
-6.65%
|
$168,607
$139.52 P/Share
|
Mar 07
2022
|
John C Roche President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,565
-9.19%
|
$1,051,535
$139.52 P/Share
|
Mar 07
2022
|
Willard T Lee Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-9.49%
|
$46,148
$139.52 P/Share
|
Mar 07
2022
|
Jeffrey M Farber Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,816
-10.03%
|
$669,424
$139.52 P/Share
|
Mar 07
2022
|
Richard W Lavey Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-6.21%
|
$260,347
$139.52 P/Share
|
Mar 02
2022
|
Richard W Lavey Executive Vice President |
SELL
Open market or private sale
|
Direct |
9,253
-13.17%
|
$1,304,673
$141.1 P/Share
|
Mar 02
2022
|
Richard W Lavey Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,253
+11.57%
|
$555,180
$60.38 P/Share
|
Feb 28
2022
|
Willard T Lee Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
628
+15.92%
|
-
|
Feb 28
2022
|
Mark Joseph Welzenbach Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
3,504
+4.93%
|
-
|
Feb 28
2022
|
Denise Lowsley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
672
+22.24%
|
-
|
Feb 28
2022
|
Bryan J Salvatore Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
4,302
+7.84%
|
-
|
Feb 28
2022
|
Richard W Lavey Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
5,002
+5.5%
|
-
|
Feb 28
2022
|
John C Roche President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,647
+8.34%
|
-
|
Feb 28
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
955
+6.07%
|
-
|
Feb 28
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
SELL
Open market or private sale
|
Direct |
3,889
-23.17%
|
$544,460
$140.0 P/Share
|
Feb 28
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,889
+18.51%
|
$455,013
$117.04 P/Share
|
Feb 28
2022
|
Dennis Francis Kerrigan Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
986
+23.25%
|
-
|
Feb 28
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
10,516
+7.2%
|
-
|
Feb 04
2022
|
Mark Joseph Welzenbach Executive Vice President |
SELL
Open market or private sale
|
Direct |
15,063
-26.53%
|
$2,093,757
$139.46 P/Share
|
Feb 04
2022
|
Mark Joseph Welzenbach Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,063
+20.68%
|
$1,656,930
$110.67 P/Share
|